title: Nitric oxide, a new second messenger involved in the action of angiotensin II on neuronal differentiation of NG108-15 cells.
abstract: Nitric Oxide (NO) is a gas that diffuses freely through membranes of target cells to activate cGMP formation. NO is synthesised from arginine, by a family of Nitric Oxide Synthase (NOS). In the brain, NO influences synaptic plasticity, apoptosis and development. It has been recently shown that angiotensin II (Ang II) could mediate NO production by its two types of receptors, AT1 and AT2. Since we have shown that Ang II, via the AT2 receptor could induce neurite outgrowth and morphological differentiation of NG108-15 cells, the aim of the study was to investigate if NO could be one of the second messengers involved in the Ang II effect. Using the Griess colorimetric assay, we found that Ang II, by its AT2 receptor, induced nitrite formation from NO. This effect was abolished by the N-nitro-L-arginine methyl ester (L-NAME), a NOS inhibitor. We also found that treatment of the cells with S-nitroso-N-acetylpenicillamine (SNAP), an exogenous source of NO, induced the same morphological differentiation. These results demonstrate that the morphological differentiation induced by the AT2 receptor is partly due to an increase in NO production.
authors.affiliation: Service of Endocrinology, Faculty of Medicine, University of Sherbrooke, Quebec, Canada.
authors.forename: F
authors.initials: F
authors.lastname: Côté
authors.forename: L
authors.initials: L
authors.lastname: Laflamme
authors.forename: M D
authors.initials: MD
authors.lastname: Payet
authors.forename: N
authors.initials: N
authors.lastname: Gallo-Payet
mesh_terms: D000804:Angiotensin II / Q000494:pharmacology / Q000502:physiology*; D000818:Animals; D002454:Cell Differentiation / Q000502:physiology; D004338:Drug Combinations; D008858:Microscopy, Phase-Contrast; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D016501:Neurites / Q000187:drug effects / Q000502:physiology; D009474:Neurons / Q000166:cytology*; D009569:Nitric Oxide / Q000502:physiology*; D020030:Nitric Oxide Donors / Q000494:pharmacology; D009573:Nitrites / Q000378:metabolism; D010396:Penicillamine / Q000031:analogs & derivatives / Q000494:pharmacology; D044139:Receptor, Angiotensin, Type 2; D011945:Receptors, Angiotensin / Q000502:physiology; D026423:S-Nitroso-N-Acetylpenicillamine; D015290:Second Messenger Systems / Q000502:physiology*; D014407:Tumor Cells, Cultured
chemical_list: D004338:Drug Combinations; D020030:Nitric Oxide Donors; D009573:Nitrites; D044139:Receptor, Angiotensin, Type 2; D011945:Receptors, Angiotensin; D000804:Angiotensin II; D009569:Nitric Oxide; D026423:S-Nitroso-N-Acetylpenicillamine; D010396:Penicillamine; D019331:NG-Nitroarginine Methyl Ester